We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Humana's (HUM) Q1 Earnings and Revenue Beat Estimates
Read MoreHide Full Article
Have you been eager to see how Humana Inc. (HUM - Free Report) performed in Q1 in comparison with the market expectations? Let’s quickly scan through the key facts from this company’s earnings release this morning.
An Earnings Beat
Humana came out with operating earnings of $4.48 per share, which beat the Zacks Consensus Estimate of $4.30.
Humana has a solid earnings surprise history. The company delivered positive surprises in each of the last four quarters, with an average beat of 5.2%.
How Was the Estimate Revision Trend?
You should note that the earnings estimate for Humana depicted neutral stance prior to the earnings release. The Zacks Consensus Estimate remained unchanged at $17.50 per share over the last seven days.
Revenues Beat Expectations
Humana posted adjusted consolidated revenues of $16.1 million, which was higher than the Zacks Consensus Estimate of $15.8 billion.
Key Q1 Statistics
Benefit expense ratio expanded 130 basis points to 86.2% in the quarter. Operating cash flow totaled $896 million, down 155.3% year over year.
2019 Guidance
For 2019, Humana expects adjusted earnings per diluted share to be in the range of $17.25 and $17.50 .
What Zacks Rank Says
Humana carries a Zacks Rank #3 (Hold). However, since the latest earnings performance yet to be reflected in the estimate revisions, the rank is subject to change. While things apparently look favorable, it all depends on what sense the just-released report makes to the analysts.
Check back later for our full write up on this Humana earnings report!
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 7 stocks to watch. The report is only available for a limited time.
Image: Bigstock
Humana's (HUM) Q1 Earnings and Revenue Beat Estimates
Have you been eager to see how Humana Inc. (HUM - Free Report) performed in Q1 in comparison with the market expectations? Let’s quickly scan through the key facts from this company’s earnings release this morning.
An Earnings Beat
Humana came out with operating earnings of $4.48 per share, which beat the Zacks Consensus Estimate of $4.30.
Humana Inc. Price and EPS Surprise
Humana Inc. Price and EPS Surprise | Humana Inc. Quote
Earnings Surprise History
Humana has a solid earnings surprise history. The company delivered positive surprises in each of the last four quarters, with an average beat of 5.2%.
How Was the Estimate Revision Trend?
You should note that the earnings estimate for Humana depicted neutral stance prior to the earnings release. The Zacks Consensus Estimate remained unchanged at $17.50 per share over the last seven days.
Revenues Beat Expectations
Humana posted adjusted consolidated revenues of $16.1 million, which was higher than the Zacks Consensus Estimate of $15.8 billion.
Key Q1 Statistics
Benefit expense ratio expanded 130 basis points to 86.2% in the quarter.
Operating cash flow totaled $896 million, down 155.3% year over year.
2019 Guidance
For 2019, Humana expects adjusted earnings per diluted share to be in the range of $17.25 and $17.50 .
What Zacks Rank Says
Humana carries a Zacks Rank #3 (Hold). However, since the latest earnings performance yet to be reflected in the estimate revisions, the rank is subject to change. While things apparently look favorable, it all depends on what sense the just-released report makes to the analysts.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on this Humana earnings report!
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 7 stocks to watch. The report is only available for a limited time.
See 7 breakthrough stocks now>>